GHRHR and diabetes mellitus: Previous studies have demonstrated the therapeutic potential of the GHRHR agonist MR409 in experimental models of diabetes (Zhang et al., 2015; Thounaojam et al., 2017; Louzada et al., 2023; Zhang et al., 2024).